EyeBio
New York, United States· Est.
EyeBio (Eyebiotech) develops innovative ophthalmology treatments, including biologics and small molecules, for retinal diseases and other eye conditions.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $65M
About
EyeBio (Eyebiotech) develops innovative ophthalmology treatments, including biologics and small molecules, for retinal diseases and other eye conditions.
OphthalmologyBiologicsSmall Molecules
Funding History
1Total raised:$65M
Venture$65M